ID

38195

Beschreibung

Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast Ca; ODM derived from: https://clinicaltrials.gov/show/NCT02144194

Link

https://clinicaltrials.gov/show/NCT02144194

Stichworte

Versionen (1)
  1. 26.09.19 26.09.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

26. September 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT02144194

Englisch

Eligibility Breast Cancer NCT02144194

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
written informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
patients >=18 years of age
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
histologically or cytologically confirmed adenocarcinoma of the breast that is now metastatic or locally-recurrent and inoperable with curative intent
Beschreibung

Breast adenocarcinoma metastatic Inoperable Curative intent | Breast adenocarcinoma recurrent Locally Inoperable Curative intent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1697918
UMLS CUI [1,2]
C0205187
UMLS CUI [1,3]
C1276305
UMLS CUI [2,1]
C0861355
UMLS CUI [2,2]
C1517927
UMLS CUI [2,3]
C0205187
UMLS CUI [2,4]
C1276305
measurable and/or non-measurable disease
Beschreibung

Measurable Disease | Non-Measurable Lesion

Datentyp

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1334988
the patient's primary and/or metastatic tumor is her2 neu negative
Beschreibung

Primary tumor HER2/Neu Negative | Metastatic Neoplasm HER2/Neu Negative

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0677930
UMLS CUI [1,2]
C2348908
UMLS CUI [2,1]
C2939420
UMLS CUI [2,2]
C2348908
documented metastatic disease previously untreated with palliative chemotherapy
Beschreibung

Neoplasm Metastasis | Chemotherapy Palliative Absent

Datentyp

boolean

Alias
UMLS CUI [1]
C0027627
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C1285530
UMLS CUI [2,3]
C0332197
adjuvant or neo-adjuvant chemotherapy (including treatment with docetaxel or any other chemotherapy) is allowed with a disease free survival of at least 6 months
Beschreibung

Chemotherapy, Adjuvant | Neoadjuvant Chemotherapy | docetaxel | Chemotherapy | Disease-Free Survival Duration

Datentyp

boolean

Alias
UMLS CUI [1]
C0085533
UMLS CUI [2,1]
C0600558
UMLS CUI [2,2]
C3665472
UMLS CUI [3]
C0246415
UMLS CUI [4]
C0392920
UMLS CUI [5,1]
C0242793
UMLS CUI [5,2]
C0449238
no symptom or sign of brain metastasis
Beschreibung

Sign or Symptom Absent Metastatic malignant neoplasm to brain

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3540840
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0220650
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
operable local recurrence
Beschreibung

Recurrence Local Operable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0034897
UMLS CUI [1,2]
C0205276
UMLS CUI [1,3]
C0205188
ascites or pericardial effusion as only site of metastasis
Beschreibung

Ascites | Pericardial effusion | Site only Neoplasm Metastasis

Datentyp

boolean

Alias
UMLS CUI [1]
C0003962
UMLS CUI [2]
C0031039
UMLS CUI [3,1]
C1515974
UMLS CUI [3,2]
C0205171
UMLS CUI [3,3]
C0027627
symptomatic peripheral neuropathy > grade 1 according to the nci common toxicity criteria
Beschreibung

Peripheral Neuropathy Symptomatic CTCAE Grades

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C0231220
UMLS CUI [1,3]
C1516728
radiotherapy to all areas of evaluable disease within the previous 4 weeks
Beschreibung

Therapeutic radiology procedure Area Evaluable Disease

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0205146
UMLS CUI [1,3]
C1516986
disease significantly affecting absorption
Beschreibung

Disease Affecting Absorption

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0237442
severe hepatic insufficiency
Beschreibung

Hepatic Insufficiency Severe

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1306571
UMLS CUI [1,2]
C0205082
patient previously treated with chemotherapy for their metastatic disease
Beschreibung

Prior Chemotherapy Neoplasm Metastasis

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0027627
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Breast Cancer NCT02144194

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
patients >=18 years of age
boolean
C0001779 (UMLS CUI [1])
Breast adenocarcinoma metastatic Inoperable Curative intent | Breast adenocarcinoma recurrent Locally Inoperable Curative intent
Item
histologically or cytologically confirmed adenocarcinoma of the breast that is now metastatic or locally-recurrent and inoperable with curative intent
boolean
C1697918 (UMLS CUI [1,1])
C0205187 (UMLS CUI [1,2])
C1276305 (UMLS CUI [1,3])
C0861355 (UMLS CUI [2,1])
C1517927 (UMLS CUI [2,2])
C0205187 (UMLS CUI [2,3])
C1276305 (UMLS CUI [2,4])
Measurable Disease | Non-Measurable Lesion
Item
measurable and/or non-measurable disease
boolean
C1513041 (UMLS CUI [1])
C1334988 (UMLS CUI [2])
Primary tumor HER2/Neu Negative | Metastatic Neoplasm HER2/Neu Negative
Item
the patient's primary and/or metastatic tumor is her2 neu negative
boolean
C0677930 (UMLS CUI [1,1])
C2348908 (UMLS CUI [1,2])
C2939420 (UMLS CUI [2,1])
C2348908 (UMLS CUI [2,2])
Neoplasm Metastasis | Chemotherapy Palliative Absent
Item
documented metastatic disease previously untreated with palliative chemotherapy
boolean
C0027627 (UMLS CUI [1])
C0392920 (UMLS CUI [2,1])
C1285530 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Chemotherapy, Adjuvant | Neoadjuvant Chemotherapy | docetaxel | Chemotherapy | Disease-Free Survival Duration
Item
adjuvant or neo-adjuvant chemotherapy (including treatment with docetaxel or any other chemotherapy) is allowed with a disease free survival of at least 6 months
boolean
C0085533 (UMLS CUI [1])
C0600558 (UMLS CUI [2,1])
C3665472 (UMLS CUI [2,2])
C0246415 (UMLS CUI [3])
C0392920 (UMLS CUI [4])
C0242793 (UMLS CUI [5,1])
C0449238 (UMLS CUI [5,2])
Sign or Symptom Absent Metastatic malignant neoplasm to brain
Item
no symptom or sign of brain metastasis
boolean
C3540840 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0220650 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Recurrence Local Operable
Item
operable local recurrence
boolean
C0034897 (UMLS CUI [1,1])
C0205276 (UMLS CUI [1,2])
C0205188 (UMLS CUI [1,3])
Ascites | Pericardial effusion | Site only Neoplasm Metastasis
Item
ascites or pericardial effusion as only site of metastasis
boolean
C0003962 (UMLS CUI [1])
C0031039 (UMLS CUI [2])
C1515974 (UMLS CUI [3,1])
C0205171 (UMLS CUI [3,2])
C0027627 (UMLS CUI [3,3])
Peripheral Neuropathy Symptomatic CTCAE Grades
Item
symptomatic peripheral neuropathy > grade 1 according to the nci common toxicity criteria
boolean
C0031117 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
Therapeutic radiology procedure Area Evaluable Disease
Item
radiotherapy to all areas of evaluable disease within the previous 4 weeks
boolean
C1522449 (UMLS CUI [1,1])
C0205146 (UMLS CUI [1,2])
C1516986 (UMLS CUI [1,3])
Disease Affecting Absorption
Item
disease significantly affecting absorption
boolean
C0012634 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0237442 (UMLS CUI [1,3])
Hepatic Insufficiency Severe
Item
severe hepatic insufficiency
boolean
C1306571 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Prior Chemotherapy Neoplasm Metastasis
Item
patient previously treated with chemotherapy for their metastatic disease
boolean
C1514457 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video